HEALTH TECHNOLOGY ASSESSMENT: The Pharmaceutical Industry Perspective
The DOI matches its Crossref record.
Abstract
Increasingly, health technology assessment (HTA) is used to aid decisions on the reimbursement of pharmaceuticals or recommendations for their use. The pharmaceutical industry seeks to work in partnership with HTA agencies; however, this presents a number of challenges. Clinical trials will need to include appropriate measures that capture economic and patient benefits as well as relevant clinical endpoints, and the industry will want to seek international harmonization of the many guidelines for economic evaluation. The problem of demonstrating cost-effectiveness of a product before it is available for use must be addressed, possibly by conditional reimbursement to allow collection of real world evidence. It is also important that reimbursement decision makers minimize bias, play fair, and adhere to the written rules they issue. If the industry fairly demonstrates the value of a product using the best available evidence, HTA agencies should be transparent in the rationale for their recommendations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Angelis, A., Lange, A., & Kanavos, P. (2018) · The European Journal of Health Economics · doi:10.1007/s10198-017-0871-0 · Cited by 305
Murray, J., Farrington, D. P., & Eisner, M. P. (2009) · Journal of Experimental Criminology · doi:10.1007/s11292-008-9066-0 · Cited by 280
D'Ambruoso, L., Abbey, M., & Hussein, J. (2005) · BMC Public Health · doi:10.1186/1471-2458-5-140 · Cited by 274
Quality, Innovation, and Value for Money: NICE and the British National Health Service
Pearson, S. D., & Rawlins, M. D. (2005) · JAMA · doi:10.1001/jama.294.20.2618 · Cited by 160
Iliffe, S., Curran, H. V., Collins, R., Yuen Kee, S. C., Fletcher, S., & Woods, B. (2004) · Aging & Mental Health · doi:10.1080/13607860410001669778 · Cited by 67
Metadata
- Authors
- Schubert, F.
- Venue
- International Journal of Technology Assessment in Health Care
- Publisher
- Cambridge University Press (CUP)
- Published
- 2002-04
- Volume
- 18
- Issue
- 2
- Pages
- 184-191
- ISSN
- 0266-4623 (ISSN-L)
- 1471-6348
- OpenAlex
- W2442369642
- Cited by
- 62
- References
- 0
- FWCI
- 11.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: HEALTH TECHNOLOGY ASSESSMENT: The Pharmaceutical Industry Perspective. https://app.cochat.ai/papers/10.1017/s0266462302000193
- The paper
- Schubert, F. (2002). HEALTH TECHNOLOGY ASSESSMENT: The Pharmaceutical Industry Perspective. International Journal of Technology Assessment in Health Care. https://doi.org/10.1017/s0266462302000193
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.